🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Orthofix Medical Inc. OFIX R2K

Healthcare · Medical Devices · United States
https://orthofix.com

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

READ MORE ›
$9.27
-17.60% 1Y

Market & Price

Market Cap
$374.71M
Current Price
$9.27
High / Low (52W)
$16.23 / $9.27
Beta
0.79

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
13.06
PEG Ratio
48.83
Book Value
$10.78
Price to Book
0.86
P/S
0.45
EV/EBITDA
30.39
Dividend Yield
-

Profitability & Returns

ROCE
-10.78%
ROE
-13.43%
ROA
-3.25%
Profit Margin
-7.27%
Op Margin
-6.75%
EPS (Latest Qtr)
$-0.52
EPS (TTM)
$-1.50

Balance Sheet & Liquidity

Debt/Equity
0.60
Quick Ratio
1.60
Current Ratio
2.87
Debt
$262.26M
Total Assets
$850.65M
Current Assets
$416.85M
Working Capital
$246.37M

Ownership

Promoter Holding
1.86%
Chg in Prom Hold
-
FII / Inst Holding
92.03%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$516.69M
Total Revenue (TTM)
$825.37M
EBITDA
$17.00M
Free Cash Flow
$22.02M
Operating Cash Flow
$34.13M
Shares Outstanding
40.42M
Gross Margin
71.01%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
21.30%
Profit 5Y
-122.27%
Revenue (YoY)
1.60%
Earnings (YoY)
-

PROS

  • Compounding revenue at 21.3% over 5 years.
  • Generates positive free cash flow.

CONS

  • Earnings shrank at -122.3% CAGR over 5 years.
  • Trading 42.9% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 OFIX Orthofix Medical Inc. R2K 9.27 - $374.71M - -10.78% -13.43% 21.30% -122.27%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------102.74M108.94M105.25M116.90M108.71M111.55M111.71M121.08M109.11M115.85M113.50M121.49M104.82M73.14M110.98M105.59M121.39M112.43M106.42M118.07M114.00M175.20M187.02M184.01M188.61M198.62M-193.65M203.12M205.63M219.91M196.71M
Cost of Revenue -----------------------------------72.03M63.59M57.11M63.57M57.16M
Gross Profit 70.42M79.04M77.29M83.21M76.54M81.56M78.62M85.22M80.16M85.77M81.53M93.33M84.56M88.71M87.69M95.45M85.40M90.04M88.60M95.30M81.41M49.97M84.74M79.68M93.95M84.12M78.10M86.47M83.42M110.33M119.55M119.76M127.24M134.75M-121.62M139.53M148.52M156.34M139.55M
Operating Expenses -----------------------------------171.10M156.30M166.00M155.19M153.23M
Operating Income -7.19M4.93M4.14M7.38M7.08M-2.69M9.27M7.42M5.92M8.00M9.03M17.86M7.87M5.92M3.91M12.40M-4.45M451.00K-18.88M4.09M6.85M-21.00M4.17M-2.92M4.27M-313.00K-3.08M6.64M-5.79M-59.71M-36.63M-24.45M-29.34M-24.91M--49.48M-16.77M-17.47M1.15M-13.69M
EBITDA ------------------------------------11.95M7.72M-3.06M17.21M-619.00K
Interest Expense -----------------------------------4.51M3.95M4.68M4.35M5.66M
Pretax Income ------------------------------------52.13M-14.22M-22.26M-2.19M-20.83M
Tax Provision -----------------------------------961.00K-142.00K533.00K30.00K74.00K
Net Income -8.38M3.57M-1.37M3.37M3.84M-7.44M9.90M-3.24M-2.65M3.85M3.46M1.57M5.23M925.00K-1.21M8.87M897.00K-547.00K-40.50M11.69M25.66M-18.42M4.65M-5.82M2.42M-2.17M-4.46M2.49M-10.72M-60.94M-39.43M-28.86M-36.02M-33.44M--53.09M-14.08M-22.80M-2.22M-20.91M
Diluted EPS -0.450.19-0.070.180.20-0.410.54-0.18-0.150.210.190.080.270.05-0.070.460.05-0.03-2.140.601.32-0.960.24-0.300.120.11-0.220.12-0.53-1.71-1.07-0.77-0.95-0.88--1.35-0.36-0.57-0.06-0.52
R&D Expense 5.84M6.45M6.52M-7.64M6.80M6.86M-7.42M6.89M6.93M-6.94M7.89M9.60M-9.23M8.98M7.98M-9.96M8.77M9.96M10.90M13.12M12.36M11.21M12.76M11.94M23.31M19.42M18.56M19.49M18.05M17.29M19.77M15.93M14.77M-15.32M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------409.79M433.82M453.04M459.95M406.56M-460.71M746.64M799.49M822.31M
Cost of Revenue -------------123.54M260.37M253.61M256.30M
Gross Profit 407.19M370.17M346.44M339.46M290.70M303.37M309.96M321.94M340.79M356.41M359.35M304.67M-337.17M486.27M545.88M566.02M
Operating Expenses -------------366.04M628.03M623.60M648.59M
Operating Income 63.88M66.25M5.90M74.87M-11.19M17.14M9.26M21.07M40.81M30.09M-18.78M-6.27M--28.87M-141.76M-77.72M-82.57M
EBITDA -------------15.66M-79.49M-18.28M9.93M
Interest Expense -------------1.29M8.63M29.63M17.49M
Pretax Income --------------17.71M-148.68M-123.88M-90.81M
Tax Provision -------------2.04M2.72M2.12M1.38M
Net Income -44.21M-18.11M42.85M-28.81M-8.54M-2.81M3.06M6.22M13.81M-28.46M2.52M--19.75M-151.40M-126.00M-92.19M
Diluted EPS 1.422.47-0.992.21-1.54-0.46-0.150.170.340.72-1.510.13--0.98-4.12-3.30-2.33
R&D Expense 31.46M27.96M22.86M28.58M26.77M24.99M26.39M28.80M29.70M33.22M34.64M39.06M49.62M49.06M80.23M73.64M65.85M

Compounded Sales Growth

5 Years:21.30%
1 Year:1.60%

Compounded Profit Growth

5 Years:-122.27%
1 Year:-

Stock Price Performance

1 Year:-17.60%
6 Months:-42.53%
3 Months:-31.49%
1 Month:-19.32%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Mar 2012Jun 2012Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --603.99M704.47M694.11M530.39M539.57M472.90M464.15M446.32M415.52M411.98M403.97M434.00M411.05M392.96M400.22M372.10M405.35M466.64M495.62M525.86M-458.63M925.32M893.29M850.65M
Current Assets -----------------------255.99M420.44M433.29M416.85M
Cash & Equivalents 14.59M13.33M13.56M32.74M---30.77M---28.92M---36.81M63.66M39.57M81.16M69.62M69.72M96.29M-50.70M33.11M83.24M82.03M
Inventory -----------------------100.15M222.17M189.45M172.32M
Receivables -----------------------82.86M128.10M134.71M135.75M
Total Liabilities --303.10M389.30M381.73M205.20M193.60M105.06M103.18M114.17M108.53M116.11M103.41M128.79M106.03M93.33M109.91M108.63M108.75M131.24M167.99M169.00M-121.77M326.58M390.17M400.61M
Current Liabilities --83.53M185.81M---62.19M---70.35M---66.44M81.99M83.44M79.41M85.91M84.88M103.90M-83.62M165.22M168.63M170.48M
Long Term Debt ------------------------93.11M157.01M157.39M
Total Debt -----------------------21.53M117.07M179.63M178.44M
Total Equity 202.06M240.27M300.89M292.07M312.37M325.20M345.97M356.44M360.98M332.15M306.99M295.86M300.56M305.21M305.02M299.63M290.31M263.48M296.61M335.40M327.63M356.86M-336.86M598.73M503.12M450.04M
Shares Outstanding -----------------------20.16M37.16M38.49M39.83M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow ----67.04M51.16M43.61M59.08M38.97M49.92M32.03M74.27M--11.54M-45.75M25.79M33.35M
Investing Cash Flow -22.29M-2.15M-31.01M--31.05M-19.95M-38.35M-21.95M-16.47M-61.00M-22.92M-52.33M--24.53M-33.13M-27.58M-34.60M
Financing Cash Flow -29.95M-40.03M-13.66M--38.35M-20.20M24.73M-46.11M3.54M2.99M-10.69M3.25M--78.00K65.32M50.71M-786.00K
Capital Expenditure -20.91M-25.84M-24.96M-27.99M-24.79M-18.07M-27.20M-16.43M-14.66M-13.59M-19.00M-15.48M--23.16M-62.05M-34.88M-34.63M
Free Cash Flow ----42.26M33.09M16.41M42.64M24.31M36.33M13.04M58.79M--34.70M-107.80M-9.09M-1.28M
Net Change in Cash --------------36.15M-13.56M48.92M-2.04M
Share Buybacks ----39.49M-11.57M63.42M---------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------78.6%78.6%78.7%78.1%74.9%-73.2%65.1%68.3%68.8%
Operating Margin % -------5.1%9.4%6.6%-4.1%-1.5%--6.3%-19.0%-9.7%-10.0%
Net Margin % -------0.7%1.4%3.0%-6.2%0.6%--4.3%-20.3%-15.8%-11.2%
ROE % -14.7%-6.2%12.0%-9.7%-2.8%-1.0%1.2%2.1%4.1%-8.7%0.7%--5.9%-25.3%-25.0%-20.5%
ROCE % -12.7%1.1%18.2%-3.3%5.2%2.9%7.3%12.5%7.9%-4.6%-1.5%--7.7%-18.7%-10.7%-12.1%

Shareholding Pattern

Insiders
1.86%
Institutions
92.03%
Public Float
93.77%

Top Institutional Holders

#Holder% HeldSharesValue
1 Engine Capital Management, LP 10.86% 4.39M $40.70M
2 Juniper Investment Company, LLC 9.84% 3.98M $36.87M
3 Rubric Capital Management LP 9.21% 3.72M $34.50M
4 Paradigm Capital Management 8.18% 3.30M $30.64M
5 Blackrock Inc. 7.94% 3.21M $29.74M
6 Armistice Capital, LLC 6.68% 2.70M $25.03M
7 Vanguard Capital Management LLC 4.10% 1.66M $15.35M
8 Millennium Management Llc 2.64% 1.07M $9.89M
9 Geode Capital Management, LLC 2.32% 938.88K $8.70M
10 State Street Corporation 2.24% 907.43K $8.41M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for OFIX

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks